Alternatively, other approaches include leveraging the vulnerabilities of these cancer cells due to Myc-driven phenotypes such as genomic instability, altered mitotic spindle morphology, and increased sensitivity to antimitotic agents24–26. The gene discussed is MYC; the disease is cancer.